New Trials: Sputnik Light, single dose vaccine

MOSCOW, February 18. /TASS/. International clinical trials of the Sputnik Light single-dose vaccine have begun in the Russian capital, Moscow Mayor Sergei Sobyanin wrote in a blog post on Thursday. “Today, we are launching international clinical trials of the Sputnik Light vaccine. The new vaccine developed by the Gamaleya Institute is meant to eliminate the main disadvantage of the classic Sputnik V – the presence of two components administered to patients at an interval of several weeks. To get vaccinated with Sputnik Light, a person will need only one visit to an outpatient clinic. Immunity will begin to develop a week later, and it will reach the maximum level four weeks after the vaccination,” the mayor wrote.

Source: Moscow kicks off clinical trials of Sputnik Light jab – Society & Culture – TASS

Hmm…

WtR

kKEETON @ Windows to Russia…

Permission to reprint in whole or in part is gladly granted, provided full credit is given...

Friendly Comment

Your email address will not be published. Required fields are marked *

Be nice or get removed! Very simple and straight forward...